₹ 225.40
4.80 (2.18%)
H
Hikal
₹ 225.40
Hikal EPS Summary (consolidated)
The latest quarterly EPS of Hikal as of Q2 Sep 2026 stands at ₹-0.49. This is a 18.33% growth quarter on quarter and 82.69% growth same quarter last year. For the FY2026 the EPS of Hikal stands at ₹-3.96. This is a 153.80% fall compared with FY2025.
Hikal EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

